en
E-mail us

Crystal Pharmatech is pleased to announce our new webinar series: "Molecules-to-Medicine: Accelerating Drug Development through Collaboration". Purpose: To communicate the extraordinary ingenuity taking place in 21st century drug discovery and development and that a good idea is just the first step in creating a medicine. In a nutshell, why CMC matters and how collaboration can accelerate development. Presenters: Innovative pharmaceutical scientists and entrepreneurs showcasing novel therapeutic technologies with a focus on how a molecule becomes a medicine.

The Role of Collaboration in Optimizing the Development of HIF Inhibitors for the Treatment of Advan
Molecules-to-Medicine: Accelerating Drug Development through Collaboration
17 Jun 2021
The Role of Collaboration in Optimizing the Development of HIF Inhibitors for the Treatment of Advan
Repurposing Dexmedetomidine into an Oral Sleep-Enhancing Medication
Molecules-to-Medicine: Accelerating Drug Development through Collaboration
19 May 2021
Repurposing Dexmedetomidine into an Oral Sleep-Enhancing Medication
The Purpose Behind Molecules to Medicine
Molecules-to-Medicine: Accelerating Drug Development through Collaboration
22 Apr 2021
The Purpose Behind Molecules to Medicine
Contact Us
bd_global@crystalpharmatech.com +1-609-604-8303
U.S
Suite 500-B, 3000 Eastpark Blvd, Cranbury, New Jersey 08512, USA
Canada
6800 Kitimat Rd, Unit 1, Mississauga, Ontario, Canada L5N 5M1
China
Suite B4-101, Biobay, 218 Xinghu Street, Suzhou Industrial Park, Suzhou, China, 215123
Suite 500-B, 3000 Eastpark Blvd, Cranbury, New Jersey 08512, USA
bd_global@crystalpharmatech.com +1-609-604-8303